Alpha-1-Proteinase Inhibitor

ATC — · 1 markets · 9 records

Alpha-1-Proteinase Inhibitor 1 markets · 9 records Forms

AU 9 records · 7 strengths

  • 1,000 mgliquidPROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vialZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial unknown
  • 4,000 mgliquidPROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial unknown
  • 500 mgliquidPROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial unknown
  • 5,000 mginjectionZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial unknown
  • 4,000 mginjectionZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial unknown
  • 1,000 mginjectionCSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial unknown

Records without a stated strength · 1 PROLASTIN C LIQUID、Prolastin-C

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.